Percutaneous bone biopsy of a superficial bone using a trocar or needle, yielding tissue for diagnostic analysis.
Verified May 8, 2026 · 7 sources ↓
- Medicare
- $223.12
- Total RVUs
- 6.68
- Global, days
- 0
- Region
- General
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 7 cited references ↓
- Identify the specific bone biopsied by name (e.g., ilium, sternum, rib, spinous process) — 'superficial bone' alone is insufficient.
- Document the clinical indication: suspected infection, malignancy, metabolic bone disease, or other specific diagnosis driving the biopsy.
- Record the technique: trocar vs. needle type, approach, number of passes, and whether imaging guidance was used.
- If imaging guidance was used, include a separate documentation entry describing the modality, real-time imaging, and final needle position.
- For bilateral or multi-site biopsies, note each anatomical site distinctly in the operative report to support modifier 59 or XS.
- Specify laterality (right vs. left) for any paired bone so RT/LT modifier usage matches the note.
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 7 cited references ↓
CPT 20220 covers a needle or trocar-based percutaneous biopsy of a superficial bone — think ilium, sternum, spinous process, or ribs. The surgeon advances the instrument through skin and soft tissue to extract cortical or cancellous bone for pathologic evaluation. Because access is percutaneous rather than open, this is the superficial counterpart to 20225, which applies to deeper targets like the vertebral body or femur. Choose the code based on the bone approached, not the technique variation.
The global period is 000, meaning standard post-op follow-up is not bundled. Every related E/M or procedure visit after the biopsy day is separately billable — but document medical necessity for each. Imaging guidance (fluoroscopy, CT, ultrasound) used to direct needle placement is not bundled into 20220 by default; report the appropriate guidance code separately and document its use in the operative note to survive NCCI scrutiny.
When the same biopsy code is needed for two anatomically distinct sites on the same date, modifier 59 (or XS for a separate structure) separates the lines. Modifier 51 applies when 20220 is the secondary procedure in a multi-procedure encounter. Payers vary on whether they accept 51 or require 59 in that scenario — know your payer mix before defaulting to one.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
| Work RVU | 1.61 |
| Practice expense RVU | 4.9 |
| Malpractice RVU | 0.17 |
| Total RVU | 6.68 |
| Medicare national rate | $223.12 |
| Global period | 0 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $223.12 |
HOPD (APC 5072) Hospital outpatient department | $1,687.37 |
ASC (PI A2) Ambulatory surgical center (freestanding) | $742.04 |
Common denial reasons
The recurring reasons claims for CPT 20220 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Missing laterality modifier (RT or LT) on paired bones causes payer suspension for manual review.
- Imaging guidance billed without documentation of real-time use triggers NCCI bundling denial.
- Duplicate claim denial when 20220 is reported twice for multi-site biopsies without modifier 59 or XS to establish distinct sites.
- Modifier 51 omitted when 20220 is a secondary procedure, resulting in downcoding or denial of the secondary line.
- Diagnosis code mismatch — vague or unspecified bone lesion ICD-10 code not supporting medical necessity for biopsy.
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 7 cited references ↓
01What separates 20220 from 20225?
02Can imaging guidance be billed separately with 20220?
03If two superficial bone biopsies are done at different sites the same day, how do you bill?
04Does 20220 have a global period requiring post-op visit bundling?
05When does modifier 26 apply to 20220?
06Is modifier 50 ever appropriate for 20220?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CMS Physician Fee Schedule 2026
- 02cms.govhttps://www.cms.gov/files/document/medicaid-ncci-policy-manual-2022-chapter-11.pdf
- 03cms.govhttps://www.cms.gov/files/document/medicaid-ncci-policy-manual-2022-introduction.pdf
- 04cgsmedicare.comhttps://www.cgsmedicare.com/medicare_dynamic/j15/partb/ptpb/ptp.aspx
- 05aapc.comhttps://www.aapc.com/codes/coding-newsletters/my-orthopedic-coding-alert/coding-tips-bone-biopsy-strategies-help-you-collect-deserved-payment-107462-article
- 06mdclarity.comhttps://www.mdclarity.com/cpt-code/20220
- 07pcgsoftware.comhttps://www.pcgsoftware.com/cpt-code-20220-under-general-excision-procedures-on-the-musculoskeletal-system
Mira AI Scribe
Mira's AI scribe captures the bone biopsied by name, the instrument used (trocar vs. needle), number of passes, laterality, and whether imaging guidance directed the procedure — all from dictation. That prevents the two most common denial triggers: missing laterality and undocumented guidance when a guidance code is billed alongside 20220.
See how Mira captures CPT 20220 documentation